Nancy Bartlett
Professor of Medicine, Division of Oncology, Koman Chair in Medical Oncology, WashU Medicine · Alvin J. Siteman Cancer Center
Credentials: · · · ·
History
- 1990–1992
Medical Oncology
Research
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
New England Journal of Medicine · 2017 · 4,914 citations
The Lancet Oncology · 2019 · 1,921 citations
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
New England Journal of Medicine · 2018 · 1,863 citations
58 papers
- BK
50 papers
50 papers
- BC
46 papers
40 papers
35 papers
34 papers
- JA
34 papers
Grants
- 2019–2032
Washington University / Siteman Cancer Center Lead Academic Site
National Cancer Institute · UG1
Contact PI · $11.3M · Washington University
- 2014–2019
Washington University/ Siteman Cancer Center Lead Academic Site
National Cancer Institute · U10
Contact PI · $7.6M · Washington University
- 2004–2015
National Cancer Institute · P30
Project lead · $875.9K · Washington University
- 1998–2015
WUMC Cancer and Leukemia Group B
National Cancer Institute · U10
Contact PI · $4.6M · Washington University
Clinical trials
- 2018–2023
Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma
Principal investigator · Terminated · Phase 1
Washington University School of Medicine
- 2014–2022
Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma
Principal investigator · Completed · Phase 1
Washington University School of Medicine
- 2013–2027
Ibrutinib in Treating Patients With Relapsed or Refractory Follicular Lymphoma
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
- 2012–2016
Phase I/II Study of Abraxane in Recurrent and Refractory Lymphoma
Principal investigator · Terminated · Phase 1
Washington University School of Medicine